CD274 and non-small cell lung carcinoma: To evaluate PD-L1 expression, we consecutively enrolled 138 NSCLC patients with definite histopathological diagnosis, sufficient tumor specimens and adequate clinical data, as well as follow up information, whose baseline characteristics were concisely presented in Table 1.